Send feedback

BSCL2 p.Arg331Cys

c.991C>T · rs773431994 · VCV879798

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.1212 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00271%, nfe)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
3
neuronopathy, distal hereditary motor, type 5A

Computational evidence

Protein change
AlphaMissense0.1212likely benign
REVEL0.518indeterminate
SaProtLLR -7.94tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 9.9GERP 1.3, phastCons 1
Regional constrainto/e 1.03unconstrained · MANE · 2,047 bp · p 0.6 · regional, not allelic
Overall
CADD31.0PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM R267C vs ClinVar R331C) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00271% European (non-Finnish) · 32/1,180,030 alleles
Filtering AF 0.00196% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00168%
Overall 0.00223% 36/1,613,984 alleles · very rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,604
European (non-Finnish)grpmax 0.00271% 36,876
Admixed American 0.00167% 59,996
Remaining individualsnot grpmax-eligible 0.0016% 62,488
African / African-American 0.00134% 74,876

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
BSCL2
Protein
p.Arg331Cys
Coding
c.991C>T
MANE Select
NM_001122955
dbSNP
rs773431994
Type
single nucleotide variant
Location
chr11:62691294 (GRCh38)
Gene constraint
LOEUF 0.869 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 75.09 · 1 PDB
Residue 331
the 'disordered' region
Full BSCL2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

neuronopathy, distal hereditary motor, type 5A — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: congenital generalized lipodystrophy type 2Charcot-Marie-Tooth disease type 2

For Distal hereditary motor neuropathy type 5 (Orphanet):

Inheritance
Autosomal dominant
Onset
Adolescent, Adult, Childhood

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bscl2-p-arg331cys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown